Literature DB >> 313707

Avascular necrosis in systemic lupus erythematosus. Silent symmetric osteonecroses.

J H Klippel, L H Gerber, L Pollak, J L Decker.   

Abstract

The symptomatic joint disease secondary to avascular necrosis of bone (ANB) in 31 of 375 (8 per cent) patients with systemic lupus erythematosus (SLE) was characterized by polyarticular (90 per cent) and symmetric (83 per cent) involvement. Progressive deterioration requiring orthopedic intervention occurred in 11 (35 per cent) patients. No distinguishing clinical or treatment differences were found comparing patients with symptomatic ANB and selected cortico-steroid-treated, asymptomatic, control subjects with SLE. Complete roentgenographic surveys revealed symmetric, polyarticular abnormalities of subchondral and cortical bone consistent with ANB in eight of 31 (26 per cent) of the control subjects. A positive correlation was found between roentgenographic ANB and disease treatment with high doses of corticosteroids. The study suggests that ANB may be present in excess of 30 per cent of the patients with SLE and is most often subclinical, asymptomatic and nonprogressive.

Entities:  

Mesh:

Year:  1979        PMID: 313707     DOI: 10.1016/0002-9343(79)90077-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel Disease.

Authors:  Vineet S Rolston; Anish V Patel; Thomas J Learch; Dalin Li; Dmitry Karayev; Chadwick Williams; Madhavi L Siddanthi; Stephan R Targan; Michael H Weisman; Dermot P B McGovern
Journal:  J Clin Rheumatol       Date:  2019-01       Impact factor: 3.517

2.  Widespread osteonecrosis of the foot in systemic lupus erythematosus: radiographic and gross pathologic correlation.

Authors:  D Resnick; C Pineda; D Trudell
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

3.  Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.

Authors:  Lidan Zhao; Xiuhua Wu; Honghua Wu; Jinmei Su; Wen Zhang; Yan Zhao; Xuan Zhang; Wenjie Zheng
Journal:  Rheumatol Int       Date:  2016-05-26       Impact factor: 2.631

4.  Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases.

Authors:  E Taccari; A Spadaro; V Riccieri; M A Grandilli; A Zoppini
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

Review 5.  Osteonecrosis in patients with SLE.

Authors:  Mahmoud Abu-Shakra; Dan Buskila; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

6.  [Unclear hip pain in systemic sclerosis. Osteonecrosis].

Authors:  M Buslau; D Spitzenberger
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

7.  Periosteal reaction in systemic lupus erythematosus.

Authors:  M Glickstein; L Neustadter; M Dalinka; M Kricun
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

8.  The immune reaction to heterologous serum causes osteonecrosis in rabbits.

Authors:  M Matsui; K Ohzono; N Nakamura; N Sugano; K Masuhara; K Nakata; K Takaoka; K Ono; T Ochi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.

Authors:  Fumio Sekiya; Ken Yamaji; Kwangseok Yang; Hiroshi Tsuda; Yoshinari Takasaki
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

10.  Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.

Authors:  Paola Caramaschi; Domenico Biasi; Ilaria Dal Forno; Silvano Adami
Journal:  Autoimmune Dis       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.